Peri-operative medical management of cerebral vasospasm

References

• Qureshi Al, Sung GY, Sun i MA, et al. Prognostic value anddeterminants of ultraearly angiographic vasospasm after aneur-ysmal subarachnoid hemorrhage. Neurosurgery 1999; 44 (5): 967–973
   PubMed Web of Science ®Google Scholar
• Qureshi Al, Suarez JI, Bhardwaj A, et al. Early predictors of outcome in patients receiving hypervolemic and hypertensive therapy for symptomatic vasospasm after subarachnoid hemor-rhage. Crit Care Med 2000; 28 (3): 824–829
   PubMed Web of Science ®Google Scholar
• Qureshi Al, Sung GY, Razumovsky AY, et al. Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. Crit Care Med 2000; 28 (4): 984–990
   PubMed Web of Science ®Google Scholar
• Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomo-graphic scanning. Neurosurgery 1980; 6 (1): 1–9
   PubMed Web of Science ®Google Scholar
• Heros RC, Zervas NT, Varsos V. Cerebral vasospasm after subarachnoid hemorrhage: An update. Ann Neurol 1983; 14 (6): 599–608
   PubMed Web of Science ®Google Scholar
• Kistler, JP, Crowell RM, Davis KR, et al. The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: A prospective study. Neurology 1983; 33 (4): 424–436
   PubMed Web of Science ®Google Scholar
• van Norden AG, van Dijk GW, van Huizen MD, et al. Interobserver agreement and predictive value for outcome of two rating scales for the amount of extravasated blood after aneurysmal subarachnoid haemorrhage. Neurol 2006; 253 (9): 1217–1220
   Web of Science ®Google Scholar
• Friedman JA, Goerss SJ, Meyer FB, et al. Volumetric quantification of Fisher Grade 3 aneurysmal subarachnoid hemorrhage: A novel method to predict symptomatic vasospasm on admission compu-terized tomography scans. Neurosurg 2002; 97 (2): 401–407
   Web of Science ®Google Scholar
• Reilly C, Amidei C, Tolentino J, et al. Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurg 2004; 101 (2): 255–261
   Web of Science ®Google Scholar
• Smith ML, Abrahams JM, Chandela S, et al. Subarachnoid hemorrhage on computed tomography scanning and the develop-ment of cerebral vasospasm: The Fisher grade revisited. Surg Neurol 2005; 63 (3): 229–234
   PubMedGoogle Scholar
• Ogilvy CS, Cheung AC, Mitha AP, et al. Outcomes for surgical and endovascular management of intracranial aneurysms using a comprehensive grading system. Neurosurgery 2006; 59 (5): 1037–1042
   PubMed Web of Science ®Google Scholar
• Rosen DS, Amidei C, Toelntino J, et al. Subarachnoid clot volume correlates with age, neurological grade, and blood pressure. Neurosurgery 2007; 60 (2): 259–266
   PubMed Web of Science ®Google Scholar
• Mocco J, Ransom ER, Komotar RJ, et al. Racial differences in cerebral vasospasm: A systematic review of the literature. Neurosurgery 2006; 58 (2): 305–314
   PubMed Web of Science ®Google Scholar
• Khurana VG, Sohni YR, Mangrum WI, et al. Section on cerebrovascular surgery: Galbraith Award: Endothelial nitric oxide synthase (eNOS) and heme oxygenase-1 (H0-1) gene polymorph-isms predict susceptibility to aneurysmal subarachnoid hemor-rhage (SAH) and post-SAH cerebral vasospasm. Clin Neurosurg 2004; 51: 343–350
   PubMedGoogle Scholar
• Khurana VG, Sohni YR, Mangrum WI, et al. Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm. J Cereb Blood Flow Metab 2004; 24 (3): 291–297
   PubMed Web of Science ®Google Scholar
• Khurana VG, Fox DJ, Meissner I, et al. Update on evidence for a genetic predisposition to cerebral vasospasm. Neurosurg Focus 2006; 21 (3): E3
   PubMedGoogle Scholar
• Borsody M, Burke A, Coplin W, et al. Haptoglobin and the development of cerebral artery vasospasm after subarachnoid hemorrhage. Neurology 2006; 66 (5): 634–640
   PubMed Web of Science ®Google Scholar
• Suzuki H, Kanamaru K, Tsunoda H, et al. Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. ] Clin Invest 1999; 104 (1): 59–66
   PubMed Web of Science ®Google Scholar
• Ono S, Zhang ZD, Marton LS, et al. Heme oxygenase-1 and ferritin are increased in cerebral arteries after subarachnoid hemorrhage in monkeys. Cereb Blood Flow Metab 2000; 20 (7): 1066–1076
   PubMed Web of Science ®Google Scholar
• Cahill J, Calvert JW, Solaro& I, et al. Vasospasm and p53-induced apoptosis in an experimental model of subarachnoid hemorrhage. Stroke 2006; 37 (7): 1868–1874
   PubMed Web of Science ®Google Scholar
• Vijay A, Santhanam R, Katusic ZS. Genetic modification of cerebral arterial wall: Implications for prevention and treatment of cerebral vasospasm. Neurol Res 2006; 28 (7): 759–768
   PubMed Web of Science ®Google Scholar
• Vermeij FH, Hasan D, Bijvoet HWC, et al. Impact of medical treatment on the outcome of patients after aneurysmal subarach-noid hemorrhage. Stroke 1998; 29 (5): 924–930
   PubMed Web of Science ®Google Scholar
• Knuckey NW, Stokes BA. Medical management of patients following a ruptured cerebral aneurysm, with epsilon-aminoca-proic acid, kanamycin, and reserpine. Surg Neurol 1982; 17 (3): 181–185
   PubMedGoogle Scholar
• Nibbelink DW, Torner JC, Henderson WG. Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage. Stroke 1975; 6 (6): 622–629
   PubMed Web of Science ®Google Scholar
• Ratnoff OD. Epsilon aminocaproic acid — a dangerous weapon. N Engl I Med 1969; 280 (20): 1124–1125
   PubMed Web of Science ®Google Scholar
• MacKay AR, Sang UH, Weinstein PR. Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases. J Neurosurg 1978; 49 (4): 597–601
   PubMed Web of Science ®Google Scholar
• Sonntag VK, Stein BM. Arteriopathic complications during treat-ment of subarachnoid hemorrhage with epsilon-aminocaproic acid. Neurosurg 1974; 40 (4): 480–485
   Web of Science ®Google Scholar
• Solomon RA, Fink ME, Lennihan L. Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage. Neurosurgery 1988; 23 (6): 699–704
   PubMed Web of Science ®Google Scholar
• Mori K, Arai H, Nakajima K, et al. Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 1995; 26 (9): 1620–1626
   PubMed Web of Science ®Google Scholar
• Origitano T, Wascher TM, Reichman OH, et al. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (“triple-H” therapy) after subarach-noid hemorrhage. Neurosurgery 1990; 27 (5): 729–739
   PubMed Web of Science ®Google Scholar
• Treggiari MM, Walder B, Suter PM, et al. Systematic review of the prevention of delayed ischemic neurological deficits with hyper-tension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. Neurosurg 2003; 98 (5): 978–984
   Web of Science ®Google Scholar
• Myburgh JA. “Triple h” therapy for aneurysmal subarachnoid haemorrhage: Real therapy or chasing numbers? Crit Care Resusc 2005; 7 (3): 206–212
   PubMedGoogle Scholar
• Harrigan, MR, Magnano CR, Guterman LR, et al. Computed tomographic perfusion in the management of aneurysmal sub-arachnoid hemorrhage: New application of an existent technique. Neurosurgery 2005; 56 (2): 304–317
   PubMed Web of Science ®Google Scholar
• Friedman JA, Pichelmann MA, Piepgras DG, et al. Pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurosurgery 2003; 52 (5): 1025–1031
   PubMed Web of Science ®Google Scholar
• Kim DH, Haney CL, van Ginhoven G. Reduction of pulmonary edema after SAH with a pulmonary artery catheter-guided hemodynamic management protocol. Neurocrit Care 2005; 3 (1): 11–15
   PubMed Web of Science ®Google Scholar
• Lee KH, Lukovits T, Friedman JA. “Triple-H” therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care 2006; 4 (1): 68–76
   PubMed Web of Science ®Google Scholar
• Lang EW, Diehl RR, Mehdorn HM. Cerebral autoregulation testing after aneurysmal subarachnoid hemorrhage: The phase relation-ship between arterial blood pressure and cerebral blood flow velocity. Crit Care Med 2001; 29 (1): 158–163
   PubMed Web of Science ®Google Scholar
• Kassell NF, Sasaki T, Colohan AR, et al. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985; 16 (4): 562–572
   PubMed Web of Science ®Google Scholar
• Wartenberg KE, Parra A. CT and CT-perfusion findings of reversible leukoencephalopathy during triple-H therapy for symptomatic subarachnoid hemorrhage-related vasospasm. J Neuroimaging 2006; 16 (2): 170–175
   PubMed Web of Science ®Google Scholar
• Davis DH, Sundt TM, Jr. Relationship of cerebral blood flow to cardiac output, mean arterial pressure, blood volume, and alpha and beta blockade in cats. Neurosurg 1980; 52 (6): 745–754
   Web of Science ®Google Scholar
• Apostol ides PJ, Greene KA, Zabramski JM, et al. Intra-aortic balloon pump counterpulsation in the management of concomitant cerebral vasospasm and cardiac failure after subarachnoid hemorrhage: Technical case report. Neurosurgery 1996; 38 (5): 1056–1059
   PubMed Web of Science ®Google Scholar
• Nussbaum ES, Heros RC, Solien EE, et al. Intra-aortic balloon counterpulsation augments cerebral blood flow in a canine model of subarachnoid hemorrhage-induced cerebral vasospasm. Neurosurgery 1995; 36 (4): 879–884
   PubMed Web of Science ®Google Scholar
• Rosen CL, Sekhar LN, Duong DH. Use of intra-aortic balloon pump counterpulsation for refractory symptomatic vasospasm. Acta Neurochir (Wien) 2000; 142 (1): 25–32
   PubMed Web of Science ®Google Scholar
• Sato K, Tokairin H, Kato M. [Two patients treated with intra-aortic balloon pump counterpulsation after subarachnoid hemorrhage]. Masui 2001; 50 (8): 859–862
   PubMedGoogle Scholar
• Spann R, Lang DA, Birch AA, et al. Intra-aortic balloon counter-pulsation: Augmentation of cerebral blood flow after aneurysmal subarachnoid haemorrhage. Acta Neurochirurg 2004; 143 (2): 115–123
   Web of Science ®Google Scholar
• Klimo P, Jr, Kestle JR, MacDonald JD, et al. Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. I Neurosurg 2004; 100 (2): 215–224
   PubMed Web of Science ®Google Scholar
• Suzuki K, Meguro K, Sakurai T, et al. Endothelin-1 concentration increases in the cerebrospinal fluid in cerebral vasospasm caused by subarachnoid hemorrhage. Surg Neurol 2000; 53 (2): 131–135
   PubMedGoogle Scholar
• Kawada S, Kinugasa K, Meguro T, et al. Experimental study of intracisternal administration of tissue-type plasminogen activator followed by cerebrospinal fluid drainage in the ultra-early stage of subarachnoid haemorrhage. Acta Neurochir (Wien) 1999; 141 (12): 1331–1338
   PubMed Web of Science ®Google Scholar
• Moriyama E, Matsumoto Y, Meguro T, et al. Combined cisternal drainage and intrathecal urokinase injection therapy for prevention of vasospasm in patients with aneurysmal subarachnoid hemor-rhage. Neurol Med Chir (Tokyo) 1995; 35 (10): 732–736
   PubMedGoogle Scholar
• Kasuya H, Shimizu T, Kagawa M. The effect of continuous drainage of cerebrospinal fluid in patients with subarachnoid hemorrhage: A retrospective analysis of 108 patients. Neurosurgery 1991; 28 (1): 56–59
   PubMed Web of Science ®Google Scholar
• Claassen J, Mayer SA, Hirsch U. Continuous EEG monitoring in patients with subarachnoid hemorrhage. I Clin Neurophysiol 2005; 22 (2): 92–98
   PubMed Web of Science ®Google Scholar
• Little A, Kerrigan JF, McDougall CG, et al. Nonconvulsive status epilepticus in patients suffereing spontaneous subarachnoid hemorrhage. Neurosurg 2007; 106: 805–811
   Web of Science ®Google Scholar
• McGirt MJ, Pradilla G, Legnani FG, et al. Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery 2006; 58 (5): 945–951
   PubMed Web of Science ®Google Scholar
• Parra A, Kreiter KT, Williams S, et al. Effect of prior statin use on functional outcome and delayed vasospasm after acute aneur-ysmal subarachnoid hemorrhage: A matched controlled cohort study. Neurosurgery 2005; 56 (3): 476–484
   PubMed Web of Science ®Google Scholar
• Tseng MY, Czosnyka M, Richards H, et al. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: A phase II randomized placebo-controlled trial. Stroke 2005; 36 (8): 1627-1632
   Google Scholar
• Tseng MY, Czosnyka M, Richards H, et al. Effects of acute treatment with statins on cerebral autoregulation in patients after aneurysmal subarachnoid hemorrhage. Neurosurg Focus 2006; 21 (3): E10
   PubMedGoogle Scholar
• Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: Results of a pilot randomized clinical trial. Stroke 2005; 36 (9): 2024–2026
   PubMed Web of Science ®Google Scholar
• Stippler M, Crago E, Levy El, et al. Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage. I Neurosurg 2006; 105 (5): 723–729
   PubMed Web of Science ®Google Scholar
• Boet R, Mee E. Magnesium sulfate in the management of patients with Fisher Grade 3 subarachnoid hemorrhage: A pilot study. Neurosurgery 2000; 47 (3): 602–606
   PubMed Web of Science ®Google Scholar
• Prevedello DM, Cordeiro JG, de Morais AL, et al. Magnesium sulfate: Role as possible attenuating factor in vasospasm morbidity. Surg Neurol 2006; 65 (Suppl. 1): 51: 14-1:20
   Google Scholar
• Wong GK, Chan MT, Poon WS, et al. Magnesium therapy within 48 hours of an aneurysmal subarachnoid hemorrhage: Neuro-panacea. Neurol Res 2006; 28 (4): 431–435
   PubMed Web of Science ®Google Scholar
• Wong G, Chan MT, Boet R, et al. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: A prospective rando-mized pilot study. Neurosurg Anesthesiol 2006; 18 (2): 142–148
   PubMed Web of Science ®Google Scholar
• Wurm G. Tomancok B, Nussbaumer K, et al. Reduction of ischemic sequelae following spontaneous subarachnoid hemor-rhage: A double-blind, randomized comparison of enoxaparin versus placebo. Clin Neurol Neurosurg 2004; 106 (2): 97–103
   PubMed Web of Science ®Google Scholar
• Suzuki R, Masaoka H, Hirata Y, et al. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurosurg 1992; 77 (1): 96–100
   Web of Science ®Google Scholar
• Shih HC, Lin CL, Lee TY, et al. 17beta-Estradiol inhibits subarachnoid hemorrhage-induced inducible nitric oxide synthase gene expression by interfering with the nuclear factor kappa B transactivation. Stroke 2006; 37 (12): 3025–3031
   PubMed Web of Science ®Google Scholar